MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by pathophysiological changes including the aggregation of amyloid beta and phosphorylated tau proteins resulting in a progressive decline in memory, cognition, and everyday functioning.